Nucleotide changes in the translated region of SCN5A from Japanese patients with Brugada syndrome and control subjects

Life Sciences

Volumn 72, Issue 21, 2003, Pages 2391-2399

  Takahata, Takenori ^a   Yasui Furukori, Norio ^a   Sasaki, Shingo ^a   Igarashi, Tomonori ^a   Okumura, Ken ^a   Munakata, Akihiro ^a   Tateishi, Tomonori ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Brugada syndrome; Idiopathic ventricular fibrillation; SCN5A

Indexed keywords

NUCLEOTIDE;

ADULT; AGED; ARTICLE; BRUGADA SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; EARLY DIAGNOSIS; FEMALE; GENE LOCATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HEART VENTRICLE FIBRILLATION; HUMAN; JAPAN; MALE; PATHOGENESIS; RNA TRANSLATION;

EID: 0037432504     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00121-8     Document Type: Article

References (21)

1. Akai J., Makita N., Sakurada H., Shirai N., Ueda K., Kitabatake A., Nakazawa K., Kimura A., Hiraoka M. A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome. FEBS Lett. 479:2000;29-34.
2. Antzelevitch C. The Brugada syndrome: diagnostic criteria and cellular mechanisms. Eur Heart J. 22:2001;356-363.
3. Baroudi G., Chahine M. Biophysical phenotypes of SCN5A mutations causing long QT and Brugada syndromes. FEBS Lett. 487:2000;224-228.
4. Baroudi G., Pouliot V., Denjoy I., Guicheney P., Shrier A., Chahine M. Novel mechanism for Brugada syndrome. Defective surface localization of an SCN5A mutant (R1432G). Circ Res. 88:2001;e78.
5. + channel mutation causing both long-QT and Brugada syndromes. Circ Res. 85:1999;1206-1213.
6. Brugada P., Brugada J. Right bundle branch block, persistent ST-segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol. 20:1992;1391-1396.
7. Chen Q., Kirsch G.E., Zhang D., Brugada R., Brugada J., Brugada P., Potenza D., Moya A., Borggrefe M., Breithardt G., Ortiz-Lopez R., Wang Z., Antzelevitch C., O'Brien R.E., Schulze-Bahr E., Keating M.T., Towbin J.A., Wang Q. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature. 392:1998;293-296.
8. Deschênes I., Baroudi G., Berthet M., Barde I., Chalvidan T., Denjoy I., Guicheney P., Chahine M. Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes. Cardiovasc Res. 46:2000;55-65.
9. Furuhashi M., Uno K., Tsuchihashi K., Nagahara D., Hyakutoku M., Ohtomo T., Satoh S., Nishiyama T., Shimamoto K. Prevalence of asymptomatic ST segment elevation in right precordial leads with right bundle branch block (Brugada-type ST shift) among the general Japanese population. Heart. 86:2001;161-166.
10. Iwasa H., Itoh T., Nagai R., Nakamura Y., Tanaka T. Twenty single nucleotide polymorphisms (SNPs) and their allelic frequencies in four genes that are responsible for familial long QT syndrome in the Japanese population. J Hum Genet. 45:2000;182-183.
11. Miyazaki T., Mitamura H., Miyoshi S., Soejima K., Aizawa Y., Ogawa S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol. 27:1996;1061-1070.
12. Priori S.G., Napolitano C., Gasparini M., Pappone C., Bella P.D., Brignole M., Giordano U., Giovannini T., Menozzi C., Bloise R., Crotti L., Terreni L., Schwartz P.J. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome. A prospective evaluation of 52 families. Circulation. 102:2000;2509-2515.
13. Rivolta I., Abriel H., Tateyama M., Liu H., Memmi M., Vardas P., Napolitano C., Priori S.G., Kass R.S. Inherited Brugada and long QT-3 syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes. J Biol Chem. 276:2001;30623-30630.
14. Rook M.B., Alshinawi C.B., Groenewegen W.A., van Gelder I.C., van Ginneken A.C.G., Jongsma H.J., Mannens M.M.A.M., Wilde A.A.M. Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome. Cardiovasc Res. 44:1999;507-517.
15. Vatta M., Dumaine R., Varghese G., Richard T.A., Shimizu W., Aihara N., Nademanee K., Brugada R., Brugada J., Veerakul G., Li H., Bowles N.E., Burugada P., Antzelevitch C., Towbin J.A. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet. 11:2002;337-345.
16. + channel associated with idiopathic ventricular fibrillation. Am J Physiol Heart Circ Physiol. 280:2001;H354-H360.
17. Wang Q., Li Z., Shen J., Keating M.T. Genomic organization of human SCN5A gene encoding the cardiac sodium channel. Genomics. 34:1996;9-16.
18. Wang Q., Shen J., Splawski I., Atkinson D., Li Z., Robinson J.L., Moss A.J., Towbin J.A., Keating M.T. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 80:1995;805-808.
19. Weiss R., Barmada M.M., Nguyen T., Seibel J.S., Cavlovich D., Kornblit C.A., Angelilli A., Villanueva F., McNamara D.M., London B. Clinical and molecular heterogeneity in the Brugada syndrome. A novel gene locus on chromosome 3. Circulation. 105:2002;707-713.
20. Yan G., Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation. 100:1999;1660-1666.
21. Yang P., Kanki H., Drolet B., Yang T., Wei J., Viswanathan P.C., Hohnloser S.H., Shimizu W., Schwartz P.J., Stanton M., Murray K.T., Norris K., George A.L. Jr., Roden D.M. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation. 105:2002;1943-1948.